医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2015年
7期
855-856
,共2页
川芎嗪%糖尿病视网膜病%缺血再灌注损伤
川芎嗪%糖尿病視網膜病%缺血再灌註損傷
천궁진%당뇨병시망막병%결혈재관주손상
Ligustrazine%Diabetes retina%Ischemia-reperfusion injury
目的：分析川芎嗪保守治疗Ⅲ期糖尿病视网膜病患者的可行性。方法：选取我院Ⅲ期DR患者70例，随机分为观察组和对照组各35例，两组均给予降糖药物的持续应用、维脑路通、云南白药、维生素类、糖尿病饮食、活动指导等治疗方案，观察组在此基础上给予川芎嗪静脉滴注。观察两组患者治疗后有效率以及疾病进展情况。结果：观察组总有效率94．3％，对照组总有效率71．4％，两组总有效率经统计学分析，P＜0．05差异具有统计学意义。单从疾病进展情况来看，观察组患者无1例进展，对照组6例出现PDR ，后行玻璃体切除术，视力下降明显。两组疾病进展情况经统计学分析，P＜0．05，差异具有统计学意义。结论：川芎嗪治疗DR‐Ⅲ患者疗效显著，且能控制病情进一步发展，但其不良反应尚需进一步观察。因此应用川芎嗪治疗DR‐Ⅲ患者具有一定的可行性。
目的：分析川芎嗪保守治療Ⅲ期糖尿病視網膜病患者的可行性。方法：選取我院Ⅲ期DR患者70例，隨機分為觀察組和對照組各35例，兩組均給予降糖藥物的持續應用、維腦路通、雲南白藥、維生素類、糖尿病飲食、活動指導等治療方案，觀察組在此基礎上給予川芎嗪靜脈滴註。觀察兩組患者治療後有效率以及疾病進展情況。結果：觀察組總有效率94．3％，對照組總有效率71．4％，兩組總有效率經統計學分析，P＜0．05差異具有統計學意義。單從疾病進展情況來看，觀察組患者無1例進展，對照組6例齣現PDR ，後行玻璃體切除術，視力下降明顯。兩組疾病進展情況經統計學分析，P＜0．05，差異具有統計學意義。結論：川芎嗪治療DR‐Ⅲ患者療效顯著，且能控製病情進一步髮展，但其不良反應尚需進一步觀察。因此應用川芎嗪治療DR‐Ⅲ患者具有一定的可行性。
목적：분석천궁진보수치료Ⅲ기당뇨병시망막병환자적가행성。방법：선취아원Ⅲ기DR환자70례，수궤분위관찰조화대조조각35례，량조균급여강당약물적지속응용、유뇌로통、운남백약、유생소류、당뇨병음식、활동지도등치료방안，관찰조재차기출상급여천궁진정맥적주。관찰량조환자치료후유효솔이급질병진전정황。결과：관찰조총유효솔94．3％，대조조총유효솔71．4％，량조총유효솔경통계학분석，P＜0．05차이구유통계학의의。단종질병진전정황래간，관찰조환자무1례진전，대조조6례출현PDR ，후행파리체절제술，시력하강명현。량조질병진전정황경통계학분석，P＜0．05，차이구유통계학의의。결론：천궁진치료DR‐Ⅲ환자료효현저，차능공제병정진일보발전，단기불량반응상수진일보관찰。인차응용천궁진치료DR‐Ⅲ환자구유일정적가행성。
Objective :To analyze ligustrazine conservative treatment of stage Ⅲ the feasibility of diabetic retinal dis‐ease .Methods :Select our hospital patients with stage Ⅲ DR 70 cases were randomly divided into observation group and control group ,35 cases in the two groups for continuous use of hypoglycemic drugs ,Venoruton ,yunnan baiyao ,vita‐mins ,diabetes diet ,activities to guide treatment ,observation group on the basis of ligustrazine intravenous drip .Effi‐cient after observing two groups of patients ,and two groups of patients with the progress of the disease .Results:Ob‐servation group total effectiveness 94 .3% ,control group total effective rate 71 .4% ,two groups total effective rate af‐ter statistics analysis ,P<0 .05 difference is statistically significant .Single from the progress of the disease ,observation group of patients with no progress in 1 case and control group in 6 cases of PDR ,after vitrectomy ,decreased vision . Two groups of the progress of the disease by the statistical analysis ,P<0 .05 ,the difference is statistically significant . Conclusion:Ligustrazine DR‐Ⅲ patients with obvious therapeutic effect ,and further development to further control the condition ,but the adverse reaction still needs further observation .So DR‐Ⅲpatients treated in application of ligustrazine has certain feasibility .
